R. Garcia

No ORCID on file · 2 papers in corpus
nonrandomized-trial 1989
Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women
Annals of internal medicine ·doi:10.7326/0003-4819-111-9-723

STUDY OBJECTIVE: To assess the long-term benefit and side effects of danazol therapy, and to delineate factors influencing the responses in patients with autoimmune thrombocytopenia. DESIGN: Before and after trial. SETTING: Referral-based…

nonrandomized-trial 1989
Very low dose danazol in idiopathic thrombocytopenic purpura and its role as an immune modulator
The American journal of the medical sciences ·doi:10.1097/00000441-198910000-00002

Danazol, an attenuated androgen, has been used successfully at its conventional dose (400-800 mg/day) in the treatment of idiopathic thrombocytopenic purpura (ITP). To minimize side effects, the authors tried a very low dose (50 mg/day) reg…